[1]
AGGARWAL, D. et al. 2025. QUALITY BY DESIGN DRIVEN FORMULATION DEVELOPMENT AND OPTIMIZATION OF POOR SOLUBLE ANTI-HYPERTENSIVE DRUG FOR IMPROVED SOLUBILITY. International Journal of Applied Pharmaceutics. 17, 4 (Jul. 2025), 231–240. DOI:https://doi.org/10.22159/ijap.2025v17i4.53836.